Invited Speaker
37th TROG Cancer Research Annual Scientific Meeting 2025
Days
Tuesday, 18th March
Wednesday, 19th March
Thursday, 20th March
Friday, 21st March
Search
Speakers
NRG-HN014 | TD 24.02: Randomized Phase III Trial of Peri-operative Immunotherapy with Response-adjusted Surgery versus Standard-of-Care (SOC) Surgery for Resectable Stage III/IV Cutaneous Squamous Cell
(#35)
Danny Rischin
1
Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia
Content is not available at the time of publishing.